{"product_id":"prognosis-of-advanced-bronchopulmonary-cancer-von-hamida-kwas","title":"Prognosis of advanced bronchopulmonary cancer","description":"\u003cp\u003eIntroduction: Primary bronchopulmonary cancer represents the leading cause of cancer mortality in men worldwide. Objective: To evaluate the prognosis of patients with locally advanced and metastatic non-small cell lung carcinoma (NSCLC) and to determine prognostic factors at these stages. Methods: Retrospective study including 140 cases of locally advanced and metastatic NSCLC diagnosed in our department between 2003 and 2013. Results: The mean age was 61±10 years with a clear male predominance. The cancer was stage IIIA in 14%, IIIB in 27% and IV in 59%. Survival at 6 months and 1 year was 50-74% and 9-25%, respectively. Survival was significantly longer in patients with stage III cancer, a performance status (PS) of 0 to 1, comorbidities, prolonged time to positive diagnosis, short treatment time, and who received specific antitumor therapy. Conclusion: Prognostic factors for advanced NSCLC are PS, stage, comorbidities, time to management, and specific antitumor therapy.\u003c\/p\u003e\u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9786205964033\"\u003e\u003ch3\u003e\u003c\/h3\u003e\u003c\/div\u003e","brand":"Autorenwelt Shop","offers":[{"title":"Softcover - 9786205964033","offer_id":46738193482053,"sku":"9786205964033","price":60.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/d79a1cde-d082-4721-abcf-f1675bf96b34.jpg?v=1758606559","url":"https:\/\/shop.autorenwelt.de\/en\/products\/prognosis-of-advanced-bronchopulmonary-cancer-von-hamida-kwas","provider":"Autorenwelt Shop","version":"1.0","type":"link"}